Internal Medicine, Hematology & Oncology · Maplewood, MN
NPI
1497723514
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1580 Beam Ave
Maplewood, MN, 55109
Phone (651) 779-7978
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
236,711 services
Medicare patients, 2024
633
Average age 75
Drug cost, 2024
$8.1M
2,196 prescriptions
Company payments, 2024
$187
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Delaune was code J0185 (injection, aprepitant, 1 mg), 22,620 times for 78 patients. In total Robert Delaune billed 236,711 services in 175 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0185 Injection, aprepitant, 1 mg | Office | 22,620 | 78 | $1.34 | $30K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 22,000 | 34 | $42.22 | $929K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 18,870 | 17 | $0.28 | $5,309 |
| J9171 Injection, docetaxel, 1 mg | Office | 18,380 | 59 | $0.70 | $13K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 14,380 | 16 | $2.32 | $33K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 12,700 | 15 | $0.05 | $695 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 10,080 | 12 | $39.30 | $396K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,790 | 13 | $0.06 | $367 |
| J0897 Injection, denosumab, 1 mg | Office | 3,180 | 20 | $20.76 | $66K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,827 | 28 | $0.09 | $257 |
| Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | Office | 2,230 | 15 | $16.90 | $38K |
| J9043 Injection, cabazitaxel, 1 mg | Office | 2,100 | 18 | $168.16 | $353K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,082 | 44 | $0.23 | $475 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,040 | 90 | $0.71 | $1,438 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,960 | 91 | $0.09 | $167 |
By year: 2022 $3.5M for 209,156 services; 2023 $3.6M for 232,504 services; 2024 $4.0M for 236,711 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 990 | 312 | $7.57 | $7,491 |
| 80053 Clinical Chemistry | 889 | 313 | $10.28 | $9,142 |
| 36415 Venipuncture Blood Collection | 750 | 278 | $8.58 | $6,434 |
| 82784 Immunoassay | 483 | 73 | $9.11 | $4,402 |
| 83521 Immunoassay | 244 | 56 | $16.93 | $4,130 |
| 82728 Clinical Chemistry | 191 | 95 | $13.36 | $2,552 |
| 83550 Clinical Chemistry | 187 | 92 | $8.57 | $1,603 |
| 83540 Clinical Chemistry | 187 | 92 | $6.34 | $1,186 |
| 85046 Blood Count | 187 | 96 | $5.39 | $1,008 |
| 84165 Clinical Chemistry | 123 | 61 | $10.53 | $1,295 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert Delaune prescribed most often to Medicare patients was Prednisone, with 185 prescriptions and refills. In total Robert Delaune wrote 2,196 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 185 | 202 | 39 | $861 |
| Hydroxyurea Generic | 129 | 297 | 31 | $3,526 |
| Dexamethasone Generic | 109 | 124 | 40 | $1,615 |
| Acyclovir Generic | 107 | 127 | 20 | $1,200 |
| Abiraterone Acetate Generic | 93 | 93 | 17 | $66K |
| Xarelto Rivaroxaban | 85 | 114 | 15 | $62K |
| Gabapentin Generic | 84 | 91 | 23 | $847 |
| Revlimid Lenalidomide | 79 | 79 | 11 | $1.4M |
| Imbruvica Ibrutinib | 78 | 79 | 11 | $813K |
| Anastrozole Generic | 67 | 152 | 14 | $1,691 |
| Imatinib Mesylate Generic | 55 | 62 | Under 11 | $6,016 |
| Lenalidomide Generic | 53 | 53 | Under 11 | $739K |
| Xtandi Enzalutamide | 44 | 44 | Under 11 | $552K |
| Venclexta Venetoclax | 44 | 44 | Under 11 | $488K |
| Eliquis Apixaban | 42 | 48 | Under 11 | $27K |
Brand drugs: 705 claims; generic drugs: 1,491 claims; opioid claims: 95.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Robert Delaune $187 ($187 in general payments such as food, travel and fees) from 1 company. The largest payer was Intera Oncology, Inc with $187.
| Company | Payments | Amount |
|---|---|---|
| Intera Oncology, Inc | 1 | $187 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.